<DOC>
	<DOCNO>NCT00548158</DOCNO>
	<brief_summary>We study patient diabetes proper medical care administer approve drug . Our interest drug sideeffect vision drug may cause swell retina .</brief_summary>
	<brief_title>Effect Pioglitazone Therapy Type 2 Diabetes Vision</brief_title>
	<detailed_description>To evaluate safety pioglitazone treatment diabetes . Recent report suggest oral glitazone treatment may cause exacerbate retinal edema . We hypothesize glitazone treatment may cause subclinical edema evidence increased retinal thickness . We conduct double-masked , prospective safety study 19 subject undergoing placebo-controlled treatment pioglitazone . Patient treatment consist either insulin placebo insulin pioglitazone . The main outcome measure ETDRS visual acuity retinal thickness measure optical coherence tomography .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Male female patient type 2 diabetes mellitus insulin therapy , 3075 year age Hgb 1c value 7.5 10 % BMI &lt; 40kg/m2 . Patients enrol stable antihypertensive lipid regimen 90 day prior study randomization . Patients must ability understand requirement study , provide write consent agree abide study requirement . Prior treatment sulfonylurea , metformin within 21 day study entry , prior treatment NSAIDs , diuretic within 21 day screen , serum creatinine level 1.5 mg/dl male 1.4 female creatinine clearance le 70 ml/min Cockcroft Gault , serum albumin level less 2.5 gm/dl . Other exclusion criterion elevate hepatic enzyme ( aspartate aminotransferase alanine aminotransferase 2.5 time upper limit normal ) uncontrolled untreated significant pulmonary , neurological condition , cardiovascular disease , include hypertension , congestive heart failure ( specifically New York Heart Association Type III IV patient ) , angina , peripheral vascular disease , great +1 peripheral edema . Furthermore , patient condition would jeopardize safety affect validity trial result exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>diabetes</keyword>
</DOC>